Innovative therapies allow for global innovative commercialization strategies. That’s why we’ve built a comprehensive integrated commercial services company, powered by more than 2,000 employees, to partner with Global pharmaceutical, biotech and emerging innovators to bring their products to market, with focus on the US market, reducing cost and risk while simultaneously improving outcomes.
From European biotech companies launching their first product in rare or established brands navigating the complex US regulatory landscape, EVERSANA is the end-to-end commercialization partner.
With established, mature infrastructure, we can support:
- CLINICAL TRIAL RECRUITMENT
- PATIENT ENGAGEMENT & COMMUNICATIONS
- MARKET ACCESS & HEOR
- PHARMACY SERVICES
- ADHERENCE & NURSING SUPPORT
- REGULATORY
- CONSULTING
EVERSANA – Gold Sponsor at EyeforPharma Barcelona
Meet the EVERSANA team at the virtual EyeforPharma Barcelona, taking place on March 30-April 3, and learn the benefits of a single end-to-end commercialization partner.
EyeforPharma Barcelona
March 30-April 2
Schedule a meeting with a commercialization expert.
Conference Workshop Presented by Ed Cox and E Corbett (postponed)
Commercial Success in Digital Therapeutics: Strategies for Pharma/Biotech & DTx winning together and DTx winning on their own
The advancements of Digital Therapeutics are promising but commercial success is not always guaranteed. This presentation will explore the pitfalls and challenges of selling products into the uniquely complicated and regulated healthcare market. It will lay the groundwork for digital companies to have successful commercial strategies on their own and how Pharma and Biotech can utilize Digital Therapeutic products to maximize the impact of their drug portfolio.
This workshop will be rescheduled at a later time.
Schedule a meeting with a commercialization expert.
Learn more about our End-to-End Commercialization solutions:
[ARTICLE] Increase Your Speed to Market
[BLOG POST] Trends Disrupting Life Sciences in 2020
[PRESS RELEASE] Evoke Pharma Enters Commercialization Agreement with EVERSANA for Gimoti™
[ARTICLE] Are We Transforming the Right Way?
[RESOURCES] Commercializing Digital Therapeutics